Regional Analysis
The Americas dominate the global hypodontia market owing to a large patient population, strong government support for research & development, and high healthcare spending. Additionally, increasing awareness has fuelled the growth of the market. Europe is the second leading global hypodontia market which is followed by Asia Pacific which is the fastest growing market for hypodontia. Asia Pacific hypodontia market is majorly driven by India, and China owing to a huge patient pool, presence of huge opportunity for the market development and continuously developing healthcare sector. The Middle East and Africa contribute the least in the growth of global hypodontia market. Among the Middle East and Africa, the Middle East dominates the market of which the UAE, Saudi Arabia, and Kuwait are expected to be the major contributors. However, Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition. However, expected growth of the African market is high due to the presence of opportunities for the development of the market.
Key Players
A number of company are present in the market. However, the major companies hold a major share of the market owing to the huge brand image, broad product portfolio, and strong distribution network around the globe. In the last few years many companies have adopted the organic strategy of product launch to cement its position in the highly dynamic market. Further, the company has also invested heavily in various research & development activities to bring innovative products in the market and to cater to the unmet market needs.
The key players for the global hypodontia market are Patterson Dental (U.S.), Henry Schein (U.S.), Dentsply Sirona (U.S.), 3M (U.S.), Pfizer (U.S), Bayer AG (Germany), Straumann (Switzerland), Danaher Corporation (Switzerland), PLANMECA OY (Finland), Carestream Health, Inc. (U.S), Biolase Inc (U.S), KERR Corporation (U.S), GC orthodontics (Germany),, and American Orthodontics (U.S).
Browse Full Report @ https://www.marketresearchfuture.com/reports/hypodontia-market-5044
Market Highlights
Hypodontia or selective tooth agenesis is the failure to form one or more teeth during the developmental period. 2.6%–11% of the population across the globe suffers from this condition. The exact cause of the condition remains unknown. Increasing number of patients suffering from hypodontia drives the growth of the market. Additionally, increasing prevalence of different dental diseases have increased the demand for different treatments and boosted the growth of the market. During last decade, a number of different treatments and diagnostic devices were introduced to improve the prognosis of the condition. Well developed technology has supported the growth of the market in this region, however, high cost of the treatment may slow the market growth.
The global hypodontia market is expected to grow at a CAGR of 6.2% during the forecast period 2017-2023.
Segmentation
The global hypodontia market is segmented on the basis of causes, treatment, and end users.
On the basis of the causes, the market is segmented hormonal defects, infection, genetics, environmental, and others. Hormonal defects is further segmented into idiopathic hypoparathyroidism and pseudohypoparathyroidism. Infection is further segmented into rubella, candida, and others. Genetics is sub segmented into MSX1 and PAX9.
On the basis of the treatment, the market is segmented into paediatric dentistry, restorative dentistry, orthodontics, oral surgery, and others.
On the basis of the end users, the market is segmented into hospital & clinics, dental centers, and others.
Browse Related Reports at:
Robotic Flight Simulator Surgery Market Report- 2027 | MRFR
Hospital Furniture Market Size, Share & Trends | Forecast to 2027
Medicated Personal Care Products Market Overview, Size, Share | Industry Forecast 2027
No comments:
Post a Comment